Valuation
26% of the score
0median 56
An operating loss over the last year: there are no earnings to price.
MRVIMaravai LifeSciences Holdings, Inc.
$7.65+187% 1Y
$7.65
$2.6052 weeks$8.99
RyuScore
Seven criteria, each scored 0 to 100 on a published scale, weighted into one number.
RyuScore 42 out of 100, Below average
Below average. Maravai LifeSciences Holdings, Inc. scores higher than 31% of the 1,794 companies Ryufin scores.
Carried by capital allocation and cycle position, held back by valuation and return on new capital.
Healthcare median 29 · all companies 57
How the score has moved
At each fiscal year end, from the reports and price of the time100
67
51
42
42
2022202320242025today
The biggest move was down 33 points from 2022 to 2023, mostly valuation.
Return on capital
18% of the score
57median 34
Over 5 years the business earned 10% a year after tax on the capital it uses.
2%
8%
15%
25%
10%
None at 2% or less, full points from 25%full points
5 years agolatest -37%
Return on new capital
16% of the score
0median 49
Over 6 years yearly profit fell by 102 cents for every dollar earned. It did so while using less capital than before.
-5%
12%
-102%
None at minus 5 cents, full points from 12 centsfull points
Capital allocation
14% of the score
98median 67
How management spends the money: shares bought back or issued, and whether assets grow faster than the business they serve.
Share countDown 13.5% a year over 4 years: buybacks
1005%
-3%
-14%
0 pointsfull points
Assets against salesAssets grew -9.5% a year, sales -8.2%
9612%
-2%
-1.4%
0 pointsfull points
Cycle position
12% of the score
100median 62
Today's operating margin of -56% is -2.56x its normal 22%: near a trough. Normal is half the 7 year median, half the last four years, so a margin that has held is not taken for a peak.
2x
1.5x
1x
0.7x
-2.6x
A trough earns points, a peak costs themfull points
7 years agonow -56%
Balance sheet
8% of the score
0median 50
What the debt weighs against the profit that has to carry it.
Net debt to EBITDANet debt with no operating cash profit.
0Interest coverAn operating loss: the interest is not covered
01.5x
12x
-4.9x
0 pointsfull points
Earnings quality
6% of the score
93median 90
Whether the reported profit arrives as cash, and whether the accounts show the usual signs of stretching.
AccrualsCash ran ahead of profit by 8.2% of assets
1008%
0%
-8%
-8.2%
0 pointsfull points
Beneish M-score-2.71
85-1.50
-1.78
-2.22
-3.00
-2.71
0 pointsfull points
How the RyuScore works
Each criterion earns 0 to 100 points on the scale drawn under it, and the RyuScore is their average weighted 26, 18, 16, 14, 12, 8 and 6. Scales bend in the company's favour between their ends, so an ordinary figure is never already near zero. Where a criterion cannot be measured from the filings it is taken out and the remaining weights scale up; a company needs 60% of the weight covered, and always a price, to get a score.
Built from the company's annual and quarterly filings with the SEC and today's share price. Banks, insurers and property trusts are not scored: their debt is their raw material, so these yardsticks mean something else there. Figures as of 2026-06-30, latest annual report FY2025.